ID: ALA3823752

Max Phase: Preclinical

Molecular Formula: C20H40O3

Molecular Weight: 328.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCC[C@@H](OC(=O)CCCCCCC)[C@@H](C)O

Standard InChI:  InChI=1S/C20H40O3/c1-4-6-8-10-11-13-14-16-19(18(3)21)23-20(22)17-15-12-9-7-5-2/h18-19,21H,4-17H2,1-3H3/t18-,19-/m1/s1

Standard InChI Key:  JRSNXAQLASDXMJ-RTBURBONSA-N

Associated Targets(non-human)

Prkcd Protein kinase C delta (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 328.54Molecular Weight (Monoisotopic): 328.2977AlogP: 5.78#Rotatable Bonds: 16
Polar Surface Area: 46.53Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.62CX LogD: 6.62
Aromatic Rings: 0Heavy Atoms: 23QED Weighted: 0.29Np Likeness Score: 0.76

References

1. Ashida Y, Yanagita RC, Takahashi C, Kawanami Y, Irie K..  (2016)  Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.,  24  (18): [PMID:27436807] [10.1016/j.bmc.2016.07.011]

Source